Compare

RetinalGenix Technologies Inc. vs ALR Technologies SG Ltd. vs Nu-Med Plus, Inc. vs Stimcell Energetics Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	RetinalGenix Technologies Inc. RTGN	ALR Technologies SG Ltd. ALRTF	Nu-Med Plus, Inc. NUMD	Stimcell Energetics Inc. STME
Year ended	2025-12-31	2025-12-31	2025-12-31	2026-05-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$2.43M	-$22.06M	-$56.2K	-$895.4K
EPS (Diluted)	-$0.13	-$0.04	$0.00	n/a
Operating cash flow	-$558.4K	-$1.87M	-$48.0K	-$312.1K
Free cash flow	n/a	n/a	n/a	n/a
Cash & equivalents	n/a	n/a	n/a	n/a
Total assets	$21.0K	$47.4K	$7.9K	$81.5K
Total liabilities	$2.32M	$39.91M	$279.2K	$1.89M
Shareholders' equity	-$2.30M	-$39.86M	-$271.3K	-$1.81M
Return on year-end equity	n/a	n/a	n/a	n/a
Shares outstanding	18.75M	n/a	83.55M	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	RetinalGenix Technologies Inc.	ALR Technologies SG Ltd.	Nu-Med Plus, Inc.	Stimcell Energetics Inc.
Latest	n/a	$25.5K Ended 2023-12-31	$0 Ended 2020-12-31	$0 Ended 2024-05-31
1 year earlier	n/a	$2.4K Ended 2022-12-31	$0 Ended 2019-12-31	$2.8K Ended 2023-05-31
2 years earlier	n/a	$7.5K Ended 2021-12-31	$0 Ended 2018-12-31	n/a
3 years earlier	n/a	n/a	$0 Ended 2017-12-31	n/a
4 years earlier	n/a	n/a	$0 Ended 2016-12-31	$95.8K Ended 2020-05-31